Stefan Luzi - Gilde Healthcare

team
Venture&Growth

All team members
Stefan Luzi
Partner Therapeutics
Venture&Growth
The Netherlands

Stefan Luzi

Partner - Therapeutics
Venture&Growth

Stefan Luzi joined Gilde Healthcare in 2015. He is focusing on venture and growth capital investments in the biopharmaceutical sector. He led several investments and currently represents Gilde on the boards of Lava Therapeutics B.V. and Amphista Therapeutics Ltd.

Prior to joining Gilde, Stefan worked at Merck KGaA where he completed international assignments in the Global Business Intelligence and M Ventures divisions. Additionally, he was involved in various consulting projects spanning the pharmaceutical and chemical departments at Merck and co-moderated Merck Serono’s innovation competitions.

Stefan received a B.Sc. in Biology and M.Sc. in Biotechnology from the Swiss Federal Institute of Technology Zurich (ETH) and his MPhil in Bioscience Enterprise from the University of Cambridge. He completed his Ph.D. with Nobel Laureate Sir Gregory Winter at the MRC Laboratory of Molecular Biology in Cambridge, where he developed a bicyclic peptide-based drug discovery platform.

He is a Swiss citizen based in Gilde’s Utrecht office.

David Nicholson

Operational Partner
David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a...

Dan Secor

Senior Associate Healthtech
Venture&Growth
Dan Secor joined Gilde Healthcare in 2020 in the Cambridge office and focuses on the Healthtech sector. He was part of Gildeā€™s investment teams in Eargo, Spire Health and Nalu Medical, where he serves or...

Pieter van der Meer

Managing Partner
Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and...